(Q43405909)

23 November 2017

Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients (English)

1 reference

23 November 2017

1 reference

9

Kunitoshi Iseki

1 reference

23 November 2017

Masatomo Taniguchi

1

1 reference

23 November 2017

Masafumi Fukagawa

2

1 reference

23 November 2017

Naohiko Fujii

3

1 reference

23 November 2017

Takayuki Hamano

4

1 reference

23 November 2017

Tetsuo Shoji

5

1 reference

23 November 2017

Keitaro Yokoyama

6

1 reference

23 November 2017

Shigeru Nakai

7

1 reference

23 November 2017

Takashi Shigematsu

8

1 reference

23 November 2017

Yoshiharu Tsubakihara

10

1 reference

23 November 2017

Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy

11

1 reference

23 November 2017

1 April 2013

1 reference

Therapeutic Apheresis and Dialysis

23 November 2017

1 reference

23 November 2017

17

1 reference

23 November 2017

2

1 reference

23 November 2017

221-228

1 reference

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

23 November 2017

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Overview of regular dialysis treatment in Japan as of 31 December 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Mild hyperphosphatemia and mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Report of the annual statistical survey of the Japanese Society for Dialysis Therapy in 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Tachycardia as a predictor of poor survival in chronic haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Consistent control of mineral and bone disorder in incident hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Association of activated vitamin D treatment and mortality in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Phosphorus binders and survival on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

Effects of Serum Calcium, Phosphorous, and Intact Parathyroid Hormone Levels on Survival in Chronic Hemodialysis Patients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12030

21 January 2018

Identifiers

DOI

10.1111/1744-9987.12030

1 reference

23 November 2017

1 reference